UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4

Blood, 2011-08, Vol.118 (7), p.1952-1961

2011

Link zum Volltext

Verfügbarkeit prüfen

Sepsis-associated disseminated intravascular coagulation and thromboembolic disease

Mediterranean journal of hematology and infectious diseases, 2010-08, Vol.2 (3), p.e2010024-e2010024

2010

Link zum Volltext

Verfügbarkeit prüfen

Coagulopathy of Acute Sepsis

Seminars in thrombosis and hemostasis, 2015-09, Vol.41 (6), p.650

2015

Link zum Volltext

Verfügbarkeit prüfen

Sepsis, thrombosis and organ dysfunction

Thrombosis research, 2012-03, Vol.129 (3), p.290-295

2012

Link zum Volltext

Verfügbarkeit prüfen

Extracellular histones are major mediators of death in sepsis

Nature medicine, 2009-11, Vol.15 (11), p.1318-1321

2009

Link zum Volltext

Verfügbarkeit prüfen

Platelet Drop and Fibrinolytic Shutdown in Patients With Sepsis

Critical care medicine, 2018-03, Vol.46 (3), p.e221-e228

2018

Link zum Volltext

Verfügbarkeit prüfen

Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way

Thrombosis research, 2020-12, Vol.196, p.193-199

2020

Link zum Volltext

Verfügbarkeit prüfen

Low D-dimer levels in sepsis: Good or bad?

Thrombosis research, 2019-02, Vol.174, p.13-15

2019

Link zum Volltext

Verfügbarkeit prüfen

Coagulation-Fibrinolysis Changes During Off-Pump Bypass: Effect of Two Heparin Doses

The Annals of thoracic surgery, 2010-02, Vol.89 (2), p.421-427

2010

Link zum Volltext

Verfügbarkeit prüfen

Grape intake reduces thrombin generation and enhances plasma fibrinolysis. Potential role of circulating procoagulant microparticles

The Journal of nutritional biochemistry, 2017-12, Vol.50, p.66-73

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease

British journal of nutrition, 2020-01, Vol.123 (2), p.190-197

2020

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy

Haematologica (Roma), 2023-07, Vol.108 (7), p.1861-1872

2023

Link zum Volltext

Verfügbarkeit prüfen

D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis

Blood transfusion = Trasfusione del sangue, 2020-07, Vol.18 (4), p.304-311

2020

Link zum Volltext

Verfügbarkeit prüfen

Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A

Journal of thrombosis and haemostasis, 2020-02, Vol.18 (2), p.381-389

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism

Blood transfusion = Trasfusione del sangue, 2022-11, Vol.20 (6), p.505-515

2022

Link zum Volltext

Verfügbarkeit prüfen

Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation

Thrombosis research, 2016-02, Vol.138, p.22-29

2016

Link zum Volltext

Verfügbarkeit prüfen

FVIII/VWF complex displays a greater pro‐haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell‐based models

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-07, Vol.26 (4), p.e151-e160

2020

Link zum Volltext

Verfügbarkeit prüfen

Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors

Endocrine, 2017-05, Vol.56 (2), p.298-307

2017

Link zum Volltext

Verfügbarkeit prüfen

Influence of cell‐associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding

British journal of haematology, 2015-03, Vol.168 (6), p.911-913

2015

Link zum Volltext

Verfügbarkeit prüfen

Factor IX-Padua enhances the fibrinolytic resistance of plasma clots

Thrombosis and haemostasis, 2014-02, Vol.111 (2), p.226

2014

Link zum Volltext

Verfügbarkeit prüfen

The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins

Thrombosis and haemostasis, 2009-04, Vol.101 (4), p.782

2009

Link zum Volltext

Verfügbarkeit prüfen

Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins

Haematologica (Roma), 2009-06, Vol.94 (6), p.819-826

2009

Link zum Volltext

Verfügbarkeit prüfen

Plasminogen activator-coated nanobubbles targeting cell-bound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy

Haematologica (Roma), 2023-07, Vol.108 (7), p.1861-1872

2023

Link zum Volltext

Verfügbarkeit prüfen

Coagulation-Fibrinolysis Changes During Off-Pump Bypass: Effect of Two Heparin Doses. Commentary

The Annals of thoracic surgery, 2010, Vol.89 (2), p.421-428

2010

Link zum Volltext

Verfügbarkeit prüfen

Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran

The Journal of pharmacology and experimental therapeutics, 2016-02, Vol.356 (2), p.305

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4

Sepsis-associated disseminated intravascular coagulation and thromboembolic disease

Coagulopathy of Acute Sepsis

Sepsis, thrombosis and organ dysfunction

Extracellular histones are major mediators of death in sepsis

Platelet Drop and Fibrinolytic Shutdown in Patients With Sepsis

Extracellular histones promote fibrinolysis by single-chain urokinase-type plasminogen activator in a factor seven activating protease-dependent way

Low D-dimer levels in sepsis: Good or bad?

Coagulation-Fibrinolysis Changes During Off-Pump Bypass: Effect of Two Heparin Doses

Grape intake reduces thrombin generation and enhances plasma fibrinolysis. Potential role of circulating procoagulant microparticles

Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease

Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy

D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis

Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A

Differential effect of direct oral anticoagulants on thrombin generation and fibrinolysis in patients with atrial fibrillation and venous thromboembolism

Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation

FVIII/VWF complex displays a greater pro‐haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell‐based models

Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors

Influence of cell‐associated tissue factor concentration on the anticoagulant activity of dabigatran. A possible explanation for the reduced incidence of intracranial bleeding

Factor IX-Padua enhances the fibrinolytic resistance of plasma clots

The contribution of anti-Xa and anti-IIa activities to the profibrinolytic activity of low-molecular-weight heparins

Tissue factor-expressing monocytes inhibit fibrinolysis through a TAFI-mediated mechanism, and make clots resistant to heparins

Plasminogen activator-coated nanobubbles targeting cell-bound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy

Coagulation-Fibrinolysis Changes During Off-Pump Bypass: Effect of Two Heparin Doses. Commentary

Histones Differentially Modulate the Anticoagulant and Profibrinolytic Activities of Heparin, Heparin Derivatives, and Dabigatran

Suchergebnisse filtern